Alerts and recalls

Get emails for this topic

Guidance and regulation

• National Patient Safety Alert Supporting Information. Patient hoists and slings: incidents and case examples.
  • Guidance
  • 16 September 2026
  • Medicines and Healthcare products Regulatory Agency
• National Institute for Health and Clinical Excellence (NICE) guidelines on dental recall
  • Guidance
  • 24 March 2011
  • Department of Health and Social Care

See more guidance and regulation in this topic

News and communications

• Class 3 Medicines Recall: Norgine Limited, MOVICOL Plain 13.7g powder for oral solution, EL(26)A/41
  • 5 October 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/40
  • 1 October 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Field Safety Notices: 21 to 25 September 2026
  • 29 September 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• MHRA Safety Roundup: September 2026
  • 29 September 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39
  • 23 September 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert

See more news and communications in this topic

Research and statistics

• Valproate: Paternal exposure to valproate and risk of neurodevelopmental disorders and congenital malformations in offspring
  • 5 September 2024
  • Medicines and Healthcare products Regulatory Agency
  • Research
• Public Assessment Report of the reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets
  • 11 February 2022
  • Medicines and Healthcare products Regulatory Agency
  • Research
• Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine
  • 21 November 2019
  • Commission on Human Medicines
  • Independent report

See more research and statistics in this topic

Organisations

• Medicines & Healthcare products
  Regulatory Agency
• Department
  of Health &
  Social Care
• Commission on Human Medicines